AI Article Synopsis
Article Abstract
Among 43 pregnant women receiving multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment with bedaquiline and/or delamanid, 98% had favorable treatment outcomes. Of 31 continued pregnancies, 81% had live births with no reported malformations, and 68% of neonates had normal birth weights. Effective MDR/RR-TB treatment during pregnancy can improve maternal outcomes without harming neonates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810705 | PMC |
| http://dx.doi.org/10.1093/cid/ciad445 | DOI Listing |
Publication Analysis
Top Keywords
mdr/rr-tb treatment
8
pregnancy birth
4
birth outcomes
4
outcomes patients
4
patients multidrug-resistant
4
multidrug-resistant tuberculosis
4
tuberculosis treated
4
treated regimens
4
regimens include
4
include repurposed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!